These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32154163)

  • 21. Treatment of acute promyelocytic leukemia with arsenic trioxide: clinical and basic studies.
    Zhao WL; Chen SJ; Shen Y; Xu L; Cai X; Chen GQ; Shen ZX; Chen Z; Wang ZY
    Leuk Lymphoma; 2001; 42(6):1265-73. PubMed ID: 11911407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel differentiation-inducing therapy for acute promyelocytic leukemia with a combination of arsenic trioxide and GM-CSF.
    Muto A; Kizaki M; Kawamura C; Matsushita H; Fukuchi Y; Umezawa A; Yamada T; Hata J; Hozumi N; Yamato K; Ito M; Ueyama Y; Ikeda Y
    Leukemia; 2001 Aug; 15(8):1176-84. PubMed ID: 11480559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of arsenic trioxide (As2O3) on leukemic cells from patients with non-M3 acute myelogenous leukemia: studies of cytotoxicity, apoptosis and the pattern of resistance.
    Lehmann S; Bengtzen S; Paul A; Christensson B; Paul C
    Eur J Haematol; 2001 Jun; 66(6):357-64. PubMed ID: 11488934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolism of arsenic trioxide in acute promyelocytic leukemia cells.
    Khaleghian A; Ghaffari SH; Ahmadian S; Alimoghaddam K; Ghavamzadeh A
    J Cell Biochem; 2014 Oct; 115(10):1729-39. PubMed ID: 24819152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual effects of arsenic trioxide (As2O3) on non-acute promyelocytic leukaemia myeloid cell lines: induction of apoptosis and inhibition of proliferation.
    Rojewski MT; Baldus C; Knauf W; Thiel E; Schrezenmeier H
    Br J Haematol; 2002 Mar; 116(3):555-63. PubMed ID: 11849211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Potentiation of arsenic trioxide-induced apoptosis by retinoic acid in retinoic acid sensitive and resistant HL-60 myeloid leukemia cells].
    Huang X
    Chin Med J (Engl); 2000 Jun; 113(6):498-501. PubMed ID: 11775865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arsenic trioxide induces not only apoptosis but also autophagic cell death in leukemia cell lines via up-regulation of Beclin-1.
    Qian W; Liu J; Jin J; Ni W; Xu W
    Leuk Res; 2007 Mar; 31(3):329-39. PubMed ID: 16882451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Omega-3 and omega-6 polyunsaturated fatty acids enhance arsenic trioxide efficacy in arsenic trioxide-resistant leukemic and solid tumor cells.
    Wirtitsch M; Roth E; Bachleitner-Hofmann T; Wessner B; Sturlan S
    Oncol Res; 2009; 18(2-3):83-94. PubMed ID: 20066898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 19-Nor-1,25(OH)2D2 (a novel, noncalcemic vitamin D analogue), combined with arsenic trioxide, has potent antitumor activity against myeloid leukemia.
    Kumagai T; Shih LY; Hughes SV; Desmond JC; O'Kelly J; Hewison M; Koeffler HP
    Cancer Res; 2005 Mar; 65(6):2488-97. PubMed ID: 15781666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arsenic trioxide therapy in acute promyelocytic leukemia and beyond: from bench to bedside.
    Rojewski MT; Körper S; Schrezenmeier H
    Leuk Lymphoma; 2004 Dec; 45(12):2387-401. PubMed ID: 15621751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine.
    Wu XX; Ogawa O; Kakehi Y
    Int J Oncol; 2004 Jun; 24(6):1489-97. PubMed ID: 15138592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arsenic trioxide: acute promyelocytic leukemia and beyond.
    Bachleitner-Hofmann T; Kees M; Gisslinger H
    Leuk Lymphoma; 2002 Aug; 43(8):1535-40. PubMed ID: 12400595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study on the resveratrol and arsenic trioxide combination induced apoptosis and its mechanism on lung adenocarcinoma cells].
    Gu S; Chen C; Jiang X; Zhang Z
    Wei Sheng Yan Jiu; 2016 Jan; 45(1):87-92. PubMed ID: 26987203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of intracellular arsenic trioxide for therapeutic response in acute promyelocytic leukemia.
    Sahu GR; Jena RK
    Am J Hematol; 2005 Feb; 78(2):113-6. PubMed ID: 15682419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of arsenic trioxide on viability, proliferation, and apoptosis in human megakaryocytic leukemia cell lines.
    Lu M; Levin J; Sulpice E; Sequeira-Le Grand A; Alemany M; Caen JP; Han ZC
    Exp Hematol; 1999 May; 27(5):845-52. PubMed ID: 10340400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential augmentative effects of buthionine sulfoximine and ascorbic acid in As2O3-induced ovarian cancer cell death: oxidative stress-independent and -dependent cytotoxic potentiation.
    Ong PS; Chan SY; Ho PC
    Int J Oncol; 2011 Jun; 38(6):1731-9. PubMed ID: 21455570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients.
    Rousselot P; Labaume S; Marolleau JP; Larghero J; Noguera MH; Brouet JC; Fermand JP
    Cancer Res; 1999 Mar; 59(5):1041-8. PubMed ID: 10070961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Combination of Arsenic Trioxide (As
    Yen CM; Tsai CW; Chang WS; Yang YC; Hung YW; Lee HT; Shen CC; Sheu ML; Wang JY; Gong CL; Cheng WY; Bau DT
    Cancer Genomics Proteomics; 2018; 15(6):453-460. PubMed ID: 30343279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arsenic trioxide induces apoptosis in HTLV-I infected T-cell lines and fresh adult T-cell leukemia cells through CD95 or tumor necrosis factor alpha receptor independent caspase activation.
    Ishitsuka K; Ikeda R; Utsunomiya A; Uozumi K; Hanada S; Suzuki S; Takeuchi S; Takatsuka Y; Takeshita T; Ohno N; Arima T
    Leuk Lymphoma; 2002 May; 43(5):1107-14. PubMed ID: 12148893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of As2O3 on tissue factor, plasminogen activator inhibitor-1 and -2 expression in NB4, HL-60 and THP-1 cells].
    Xu X; Peng L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Oct; 34(4):645-9. PubMed ID: 14619570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.